A Phase 3, Randomized, Double-Blind, Placebo-Controlled,

Project: Research project

Project Details

Description

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VX-770 in Subjects with Cystic Fibrosis and G551D Mutation.
StatusFinished
Effective start/end date9/16/099/9/12

Funding

  • Vertex Pharmaceuticals Incorporated

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.